Cytoscape MOCOD analysis revealed that the goal cluster consists of CYP1A, NR1H4, PPARA, and RELA which are involved in NAFLD amelioration (Fig. 6). Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.